#gender identity
Related Stories (4)
Conflicting ideas of fairness in women’s sports fuel transgender participation debate - Reuters
Conflicting ideas of fairness in women’s sports fuel transgender participation debate Reuters
August 28, 2026Minimum age of 11 set for UK puberty blocker trial
Gender-questioning children will have to be at least 11 years old to take part in a clinical trial of puberty-blocking drugs.
June 19, 2026Australia court doubles payout for trans woman in landmark discrimination case
Roxanne Tickle has been awarded AU$40,000 in damages for being kicked off the Giggle for Girls app.
May 15, 2026Puberty blockers trial paused over concerns from medicines watchdog
The medicines regulator is suggesting the minimum age limit for trial should be raised to 14.
February 21, 2026Related Pages (5)
Minimum age of 11 set for UK puberty blocker trial
Gender-questioning children will have to be at least 11 years old to take part in a clinical trial assessing the risks and benefits of puberty-blocking drugs. The planned Pathways Trial was paused in
Tickle v Giggle: transgender woman sues female-only ‘online refuge’ for alleged discrimination in landmark case
Roxanne Tickle claims she was blocked from using the Giggle for Girls app because its CEO said she was a man An app intended as an “online refuge” for women became the site of alleged gender identity
Court upholds discrimination ruling on appeal after transgender woman excluded from Giggle for Girls app
By Jamie McKinnell Topic:Courts Fri 15 May 2026 at 2:30pm Sall Grover, centre, arrives at court ahead of the ruling. (ABC News: Liam Patrick) A court ruling that the exclusion of transgender woman
Australia court doubles payout for trans woman in landmark discrimination case
A Sydney court has doubled the discrimination payout for an Australian trans woman who was kicked off a female-only app. It comes almost two years after Roxanne Tickle successfully sued Sall Grover,
Puberty blockers trial paused over concerns from medicines watchdog
A clinical trial assessing the risks and benefits of puberty-blocking drugs in children who question their gender has been paused after safety concerns were raised by the UK medicines watchdog. The M